Dirk W. Kirsten
Fortune : 573 730 $ au 31/05/2026
Fortune : 573 730 $ au 31/05/2026
Dirk W.
Kirsten worked as Head-Group Funding & Capital Markets at Roche Holding AG from 2002 to 2004.
From 2004 to 2008, worked as Group Treasurer at Syngenta AG.
From 2008 to 2013, worked as Chief Financial Officer at Nobel Biocare Holding AG.
From 2021 to 2026, worked as Chief Financial Officer at Medartis Holding AG.
Dr. Kirsten earned a doctorate from Universität zu Köln.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MEDARTIS HOLDING AG 0,04 % | 31/12/2025 | 5 762 ( 0,04 % ) | 573 730 $ | 31/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| MEDARTIS HOLDING AG | Directeur Financier/CFO | 01/01/2026 |
| NOBEL BIOCARE HOLDING AG | Directeur Financier/CFO | 01/01/2013 |
| SYNGENTA | Treasurer | 01/01/2008 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2004 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Syngenta AG
Syngenta AG Information Technology ServicesTechnology Services Develops technologies and farming practices | Technology Services |
Nobel Biocare Holding AG
Nobel Biocare Holding AG Medical SpecialtiesHealth Technology Manfuctures and markets dental equipment, supplies, implants and devices | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medartis Holding AG
Medartis Holding AG Medical SpecialtiesHealth Technology Designs and manufactures orthopedic devices | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national